Psyence Biomedical (Psyence Biomedical) FCF Yield % : -12.31 (As of Apr. 27, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Psyence Biomedical's Trailing 12-Month Free Cash Flow is $-1.42 Mil, and Market Cap is $11.50 Mil. Therefore, Psyence Biomedical's FCF Yield % for today is -12.31%.

The historical rank and industry rank for Psyence Biomedical's FCF Yield % or its related term are showing as below:

PBM' s FCF Yield % Range Over the Past 10 Years
Min: -20.59 Med: 0 Max: 0
Current: -12.31

PBM's FCF Yield % is ranked better than
54.84% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs PBM: -12.31

Psyence Biomedical's FCF Margin % for the quarter that ended in Mar. 2023 was 0.00%.

Psyence Biomedical FCF Yield % Historical Data

The historical data trend for Psyence Biomedical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical FCF Yield % Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

FCF Yield %

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
FCF Yield %	-	-	-

Competitive Comparison of Psyence Biomedical's FCF Yield %

For the Biotechnology subindustry, Psyence Biomedical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's FCF Yield % falls into.

Psyence Biomedical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Psyence Biomedical's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.416	/	0
	=	N/A%

Psyence Biomedical's annualized FCF Yield % for the quarter that ended in Mar. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.416	*	1	/	0
	=	N/A%

Psyence Biomedical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Psyence Biomedical FCF Yield % Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024